Fig. 3From: High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective studyRelationship between patient survival and recurrence and the expression of Beclin-1 and ARID1A. Overall survival rate (a) and recurrence-free rate (b) in ICC patients with high or low Beclin-1 and ARID1ABack to article page